Exercise Tips
Fending off fitness fatigue
Runners stumble, yogis yawn, and even the bulkiest body builders get bored. But fitness experts say there are specific tricks to help people get and stay motivated. Full Article
REUTERS SHOWCASE
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
FDA says ulcer drugs may raise diarrhea risk
 |
Bringing up India
They smile, they drool, they cry -- here is a look at India's next generation. Slideshow
(Reuters) - Health regulators said ulcer drugs such as AstraZeneca Plc's blockbuster Nexium could increase the risk of clostridium difficile-associated diarrhea (CDAD).
Clostridium difficile is a bacteria naturally present in the gut and can cause colitis and other intestinal conditions.
The Food and Drug Administration said patients who develop diarrhea after taking these drugs should be checked for CDAD.
The drugs called proton pump inhibitors (PPIs) are widely used for treating ulcers, acid reflux and other conditions.
Other PPIs sold by prescription include Takeda Pharmaceutical Co Ltd's Dexilant and Prevacid, AstraZeneca's Prilosec and Vimovo, Santarus Inc's Zegerid, and Johnson & Johnson and Eisai Co Ltd's AcipHex.
Generic versions of Prevacid and Prilosec also are available.
Details were released on the FDA website at link.reuters.com/wag56s
(Reporting by Anand Basu in Bangalore; Editing by Don Sebastian)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters